CSRC sets forth disclosure requirements for listed pharma companies.
Technology Media and Telecom
- August 19, 2022
A U.S. company acquiring a Chinese company will face a multitude of regulatory restrictions and requirements. How can the U.S. acquirer manage the risk of the deal being blocked or unwound for non-compliance?
August 18, 2022CFIUS publishes data from 2021; Autonomous vehicles can be driven in simple and controlled conditions; Trust firms' loans to real estate sector audited
August 16, 2022Nate Bush and Della Ding of DLA Piper and Ray Xu of Shanghai Kaiman Law Firm assess the implications for dominant firms of recent amendments to China's key anti-monopoly legislation and proposed revisions to its implementing rules.
August 12, 2022The use of artificial intelligence to generate prescriptions is strictly prohibited
August 05, 2022Self-assessment is required before filing for security assessment of data transfer.
August 05, 2022The U.S. adds Alibaba to delisting list, citing audit non-compliance; Integration of Shenzhen and Swiss bourses; Six ESG-linked indices launched in Shenzhen
August 02, 2022SAMR defines the relevant product market for antitrust involving IP
July 29, 2022The level of cybersecurity protection requires assessment.
July 29, 2022Jianwei (Jerry) Fang and Runyang Liu of Zhong Lun Law Firm discuss the newly released rules for the transfer of data overseas and the compliance requirements provided by the Cyberspace Administration of China.
July 29, 2022





